HomeCompareCELP vs ABBV

CELP vs ABBV: Dividend Comparison 2026

CELP yields 1534.34% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CELP wins by $5.47M in total portfolio value
10 years
CELP
CELP
● Live price
1534.34%
Share price
$0.49
Annual div
$7.49
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.51M
Annual income
$41,615.09
Full CELP calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — CELP vs ABBV

📍 CELP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCELPABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CELP + ABBV cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
CELP pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CELP
Annual income on $10K today (after 15% tax)
$130,419.21/yr
After 10yr DRIP, annual income (after tax)
$35,372.83/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, CELP beats the other by $34,391.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CELP + ABBV for your $10,000?

CELP: 50%ABBV: 50%
100% ABBV50/50100% CELP
Portfolio after 10yr
$2.77M
Annual income
$21,384.77/yr
Blended yield
0.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

CELP
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CELP buys
0
ABBV buys
0
No recent congressional trades found for CELP or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCELPABBV
Forward yield1534.34%3.67%
Annual dividend / share$7.49$6.20
Payout ratio50%58%
1-year div growth0%4.7%
5-year div CAGR-50%8.9%
Portfolio after 10y$5.51M$39.9K
Annual income after 10y$41,615.09$1,154.43
Total dividends collected$3.79M$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CELP vs ABBV ($10,000, DRIP)

YearCELP PortfolioCELP Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$87,417$76,717.18$11,520$399.75+$75.9KCELP
2$406,920$313,383.17$13,261$450.98+$393.7KCELP
3$1,117,073$681,669.18$15,255$508.41+$1.10MCELP
4$2,069,714$874,445.84$17,536$572.74+$2.05MCELP
5$2,971,685$757,090.68$20,145$644.78+$2.95MCELP
6$3,687,659$507,956.48$23,126$725.38+$3.66MCELP
7$4,240,346$294,551.18$26,532$815.52+$4.21MCELP
8$4,695,440$158,269.62$30,420$916.26+$4.67MCELP
9$5,106,016$81,895.26$34,855$1,028.80+$5.07MCELP
10$5,505,053$41,615.09$39,914$1,154.43+$5.47MCELP

CELP vs ABBV: Complete Analysis 2026

CELPStock

Cypress Environmental Partners, L.P. provides independent inspection, integrity, and support services in North America. The company operates in three segments: Inspection Services, Pipeline & Process Services (PPS), and Environmental Services. The Inspection Services segment offers inspection and integrity services on various infrastructure assets, including midstream pipelines, gathering systems, and distribution systems. This segment also provides various services, such as nondestructive examination, in-line inspection support, pig tracking, survey, data gathering, and supervision of third-party contractors. The PPS segment offers hydrostatic testing, chemical cleaning, water transfer and recycling, pumping, pigging, flushing, filling, dehydration, caliper runs, in-line inspection tool run support, nitrogen purging, and drying services, as well as test documentation and records retention services. The Environmental Services segment owns and operates 9 water treatment facilities with ten environmental protection agency class II injection wells in the Bakken shale region of the Williston Basin in North Dakota. This segment offers treatment, recovery, separation, and disposal of waste byproducts generated during the lifecycle of an oil and natural gas well to protect the environment and drinking water. The company serves owners and operators of pipelines and other infrastructure, public utility or local distribution, pipeline construction, oil and natural gas exploration and production, and trucking companies, as well as third-party purchasers of residual oil. Cypress Environmental Partners GP, LLC operates as the general partner of the company. The company was formerly known as Cypress Energy Partners, L.P. and changed its name to Cypress Environmental Partners, L.P. in March 2020. Cypress Environmental Partners, L.P. was founded in 2003 and is headquartered in Tulsa, Oklahoma.

Full CELP Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this CELP vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CELP vs SCHDCELP vs JEPICELP vs OCELP vs KOCELP vs MAINCELP vs JNJCELP vs MRKCELP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.